Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 39, 2009 - Issue 3
176
Views
3
CrossRef citations to date
0
Altmetric
Commentary

Drug–drug interaction studies in preclinical species: should metabolite(s) kinetics be studied?

Pages 193-196 | Received 06 Nov 2008, Accepted 28 Nov 2008, Published online: 01 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Harilal Patel, Nirmal Desai, Prakash Patel, Nirav Modi, Krunal Soni, Nitin Dobaria & Nuggehally R. Srinivas. (2019) Differential pharmacokinetic drug-drug interaction potential of eletriptan between oral and subcutaneous routes. Xenobiotica 49:10, pages 1202-1208.
Read now

Articles from other publishers (2)

Poonam Giri, Prashant Delvadia, Meera K. Ladani, Namrata Prajapati, Lakshmikant Gupta, Nirmal Patel, Vipul Joshi, Shyamkumar Giri, Mukul R. Jain, Nuggehally R. Srinivas & Pankaj R. Patel. (2019) Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar rats. European Journal of Pharmaceutical Sciences 130, pages 107-113.
Crossref
Nuggehally R. Srinivas. (2016) Verapamil and pristimerin pharmacokinetic drug-drug interaction study in rats - perspectives. Biomedical Chromatography 30:12, pages 2074-2074.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.